Gold bars being cast at a plant by Gulidov Krasnoyarsk Non-Ferrous Metals Plant in Russia.
Gold prices eased on Monday as drugmaker AstraZeneca injected fresh optimism into the race for a COVID-19 vaccine, bolstering appetite for riskier assets and overshadowing support for bullion from a weaker dollar.
Spot gold fell 0.3% to $1,865 per ounce and U.S. gold futures fell 0.4% to $1,864.30.
The positive vaccine developments prompted investors to bet on a quicker global economic recovery, driving equities higher.
"The vaccine is not going to change the fundamentals of gold in near term ...